biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a25a-01a-12d-a16d-09
biospecimen_aliquot__bcr_aliquot_uuid	5739a7e1-7fa3-434c-b1c3-c0a9e570c858
biospecimen_aliquot__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113421768
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-06-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a16d
biospecimen_aliquot__plate_row	b
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	2.02
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a25a-01a-12d
biospecimen_analyte__bcr_analyte_uuid	491cec7e-ff47-4411-bb0e-3c87600bf158
biospecimen_analyte__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a25a
biospecimen_diagnostic_slides__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	6d311e39-9f96-4775-b9da-8d034d1ad1dc
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a25a
biospecimen_normal_control__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_normal_control__ncedna_dna_conc	0.161
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	124.2
biospecimen_portion__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_portion__bcr_portion_barcode	tcga-a2-a25a-01a-12
biospecimen_portion__bcr_portion_uuid	2984429e-172c-4128-a979-17bc7e9bcde3
biospecimen_portion__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_portion__date_of_creation	2011-05-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	12
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a25a-01a-12d
biospecimen_protocol__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_sample__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_sample__bcr_sample_uuid	57e65074-4dc7-4f55-9638-8d123702305c
biospecimen_sample__days_to_collection	2927
biospecimen_sample__initial_weight	160
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a25a.3971ca42-f1b0-4d85-9ad3-210b98e76a9c.pdf
biospecimen_sample__pathology_report_uuid	3971ca42-f1b0-4d85-9ad3-210b98e76a9c
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	bf3c63c7-643e-43b2-b5ea-3c2185ba9238
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17i
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a25a-01a-21-a17i-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
biospecimen_slide__bcr_sample_barcode	tcga-a2-a25a-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a25a-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	e00dd3e2-e129-4dc6-84a4-5a6385e8bb29
biospecimen_slide__image_file_name	tcga-a2-a25a-01a-01-tsa.e00dd3e2-e129-4dc6-84a4-5a6385e8bb29.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	2
biospecimen_slide__percent_stromal_cells	28
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a25a
biospecimen_tumor_sample__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
clinical_drug__bcr_drug_barcode	tcga-a2-a25a-d14583
clinical_drug__bcr_drug_uuid	37b653a5-16f9-4cfa-91c8-7aae12b3d81d
clinical_drug__bcr_patient_barcode	tcga-a2-a25a
clinical_drug__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
clinical_drug__form_completion_date	2011-7-22
clinical_drug__pharmaceutical_therapy_drug_name	cytoxan
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__regimen_number	2
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-a2-a25a-f30927
clinical_follow_up__bcr_followup_uuid	23da0430-b849-4d44-91a7-3099f6931b76
clinical_follow_up__bcr_patient_barcode	tcga-a2-a25a
clinical_follow_up__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-4-19
clinical_follow_up__last_contact_days_to	3276
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-a2-a25a-o12635
clinical_omf__bcr_omf_uuid	df4dbab0-9d4a-4fcd-9d0e-818366f0f5f1
clinical_omf__bcr_patient_barcode	tcga-a2-a25a
clinical_omf__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
clinical_omf__days_to_surgical_resection	29
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-6-3
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	lobular carcinoma in situ
clinical_omf__other_malignancy_laterality	right
clinical_omf__pathologic_M	m0
clinical_omf__pathologic_N	nx
clinical_omf__pathologic_T	tis (lcis)
clinical_omf__pathologic_stage	stage 0
clinical_omf__radiation_tx_indicator	no
clinical_omf__system_version	6th
clinical_patient__age_at_diagnosis	44
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-a2-a25a
clinical_patient__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
clinical_patient__birth_days_to	-16084
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	<10%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-6-21
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.1
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2003
clinical_patient__last_contact_days_to	2968
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	14
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a25a
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a25a
clinical_radiation__bcr_patient_uuid	aaea5f9c-b35b-47f8-93cb-bdc7b81844ff
clinical_radiation__bcr_radiation_barcode	tcga-a2-a25a-r14586
clinical_radiation__bcr_radiation_uuid	e691c50b-1796-4283-817c-0f5231b1908d
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-7-22
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A25A-01A-12D-A16D-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A25A-01A-12D-A16D-09.bed.meta
manually_curated__id	tcga-a2-a25a-01a-12d-a16d-09
manually_curated__md5sum	affadf8b81f075a04d41e7d8e56c0593
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	5739a7e1-7fa3-434c-b1c3-c0a9e570c858
manually_curated__tumor_tag	brca
